Navigation Links
MicroRNA cocktail helps turn skin cells into stem cells
Date:2/2/2011

LA JOLLA, Calif., February 1, 2011 Stem cells are ideal tools to understand disease and develop new treatments; however, they can be difficult to obtain in necessary quantities. In particular, generating induced pluripotent stem (iPS) cells can be an arduous task because reprogramming differentiated adult skin cells into iPS cells requires many steps and the efficiency is very low researchers might end up with only a few iPS cells even if they started with a million skin cells. A team at Sanford-Burnham Medical Research Institute (Sanford-Burnham) set out to improve this process. In a paper published February 1 in The EMBO Journal, the team identified several specific microRNAs (miRNAs) that are important during reprogramming and exploited them to make the transition from skin cell to iPS cell more efficient.

"We identified several molecular barriers early in the reprogramming process and figured out how to remove them using miRNA," said Tariq Rana, Ph.D., director of the RNA Biology program at Sanford-Burnham and senior author of the study. "This is significant because it will enhance our ability to use iPS cells to model diseases in the laboratory and search for new therapies."

"Our study not only presents new mechanistic insights about the role of non-coding RNAs during somatic cell reprogramming but also provides proof of principle using microRNAs as great enhancers for iPS cell generation," added Zhonghan Li, graduate student and first author of the study.

MiRNAs are small strands of genetic material that may play a major role in many diseases by gumming up protein production. In this study, Dr. Rana and his colleagues observed that three groups of miRNAs, including two known individually as miR-93 and miR-106b, are activated as part of a defense mechanism that occurs when cells are stressed by the standard skin cell reprogramming process. Digging deeper, they determined that miR-93 and miR-106b target two proteins cal
'/>"/>

Contact: Josh Baxt
jbaxt@sanfordburnham.org
858-795-5236
Sanford-Burnham Medical Research Institute
Source:Eurekalert

Page: 1 2

Related biology news :

1. MicroRNA suppresses prostate cancer stem cells and metastasis
2. MicroRNAs dictate the Epstein-Barr virus elaborate waiting game, cancer formation
3. Newly identified RNA sequence is key in microRNA processing
4. Red blood cells have a tiny but effective protector -- microRNA
5. Study of microRNA helps NIH scientists unlock secrets of immune cells
6. MicroRNA network study implicates rewired interactions in cancer
7. Pitt researchers discover big role for microRNA in lethal lung fibrosis
8. Penn biologists determine microRNA activity is suppressed in mouse ovum
9. Scientists use microRNAs to track evolutionary history for first time
10. MicroRNA in human saliva may help diagnose oral cancer
11. MicroRNAs help control HIV life cycle
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... 2014 C-Labs LLC, a leading provider of ... (IoT), today announced the appointment of John Traynor ... a strategic advisor to the firm, Mr. Traynor will ... is based out of the C-Labs office in ... Chris Muench , Chief Executive Officer. Photo ...
(Date:11/18/2014)... 2014   EyeLock Inc. , a market ... MorphoTrust USA (Safran), a leading U.S. provider ... strategic partnership to offer comprehensive biometric identity solutions ... airport screening and financial services markets. ... consumers through a nationwide network of 1,100 IdentoGO® ...
(Date:11/7/2014)... associate professor, biomedical engineering, in the Grove School ... York, have identified a molecule that could lead ... aggressive forms of breast cancer. , Triple negative ... owing to aggressive proliferation and metastasis and a ... team, discovered the overexpression of intercellular adhesion molecule-1 ...
Breaking Biology News(10 mins):C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
... related abnormalities like hypertension, obesity, insulin resistance, and ... heart disease and diabetes. Individuals with a genetic ... can be especially vulnerable to metabolic syndrome, but ... stearoyl-CoA desaturase-1 (SCD1), which helps synthesize unsaturated fatty ...
... Society of America, the nations professional organization of ... (www.esa.org/pao/policyStatements/#energy) that offers the ecological principles necessary for ... and reduce carbon dioxide emissions that contribute to ... the current mode of biofuels production will degrade ...
... the University of Alberta for those who may have overindulged during ... have found a way to reduce the amount of bad cholesterol ... the body metabolizes, a key discovery that could lead to new ... and heart disease related to obesity. In a series ...
Cached Biology News:Biofuels Sustainability 2Biofuels Sustainability 3University of Alberta researchers report breakthrough in lowering bad cholesterol, fatty acid levels 2
(Date:11/21/2014)... San Diego, CA (PRWEB) November 20, 2014 ... has extended their Sartorius Entris Balance promotion . ... for customers seeking a durable, high accuracy, and easy-to-maintain ... and made in Germany. It was designed to help ... is affordable and a balance that is very durable. ...
(Date:11/21/2014)... (PRWEB) November 20, 2014 The ... public policy research organization representing leading California academic ... and PwC US today released a ... life sciences industry growth. The trend shows a ... 2015 California Biomedical Industry Report indicates ...
(Date:11/21/2014)... (PRWEB) November 20, 2014 The November ... available as an open access journal featuring the following ... fluorescent proteins to preserve photoresponsiveness in the retina , ... fluorescent in situ hybridization using chromogenic substrates in zebrafish ... DNA, RNA, and protein electrophoresis , Nuclear ...
(Date:11/21/2014)... 21, 2014 Why did Stephen Hawking ... Einstein so instantly recognizable? Why have they become icons ... and author Hilton Ratcliffe seeks out the answers to ... all to do with science. In " Stephen Hawking ... November 21, 2014), Ratcliffe puts it plainly: , ...
Breaking Biology Technology:Pipette.com Announces an Extension on the Sartorius Entris Balance Promotion to the End of 2014 2California Healthcare Institute and PwC Report Boom in California’s Biomedical Industry 2California Healthcare Institute and PwC Report Boom in California’s Biomedical Industry 3California Healthcare Institute and PwC Report Boom in California’s Biomedical Industry 4BioTechniques: The International Journal of Life Science Methods Announces the Publication of the November 2014 Issue—Available in Print and Online 2BioTechniques: The International Journal of Life Science Methods Announces the Publication of the November 2014 Issue—Available in Print and Online 3“Stephen Hawking Smoked My Socks” Sparks Controversy in Science World 2“Stephen Hawking Smoked My Socks” Sparks Controversy in Science World 3“Stephen Hawking Smoked My Socks” Sparks Controversy in Science World 4
... 18 BioMarin,Pharmaceutical Inc. (Nasdaq: BMRN ) ... Bloomberg this morning. The article was based on ... of,BioMarin, held on September 17, 2008., Following ... the,information previously released publicly:, -- The Company ...
... Sept. 18 /Xinhua-PRNewswire-FirstCall/ -- Yongye Biotechnology,International, Inc. (OTC ... developer, producer and distributor of fulvic acid based,nutrients ... of China, today,released a letter to shareholders from ... Zishen Wu, summarizing some recent Company events and ...
... Cellectar, Inc., a,privately-held radiopharmaceuticals company that designs ... cancers, today announced the,appointment of Charles C. Harwood, ... Harwood, 55, is a Healthcare Industry Advisor for ... to working with Avista,Mr. Harwood was President and ...
Cached Biology Technology:BioMarin Corrects Information Included in Bloomberg Article 2BioMarin Corrects Information Included in Bloomberg Article 3Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc. 2Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc. 3Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc. 4Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc. 5Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc. 6Charles C. Harwood, Jr., Joins Cellectar, Inc.'s Board of Directors 2
ATP-binding cassette sub-family D member 4 (Peroxisomal membrane protein 69) (PMP69) (Peroxisomal membrane protein 1-like) (PXMP1-L) (P70R). [Source:Uniprot/SWISSPROT;Acc:O14678] Antigen: Recombi...
odz, odd Oz/ten-m homolog 1 [Source:RefSeq_peptide;Acc:NP_055068] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Rabbit polyclonal to FANCG ( Abpromise for all tested applications). Antigen: Synthetic peptide: MSRQTTSVGSSC, corresponding to amino acids 1 - 12 of Human FANCG. Entrez GeneID: 2189 Swis...
...
Biology Products: